Review findings
46 finding(s) · status completed · 2026-06-15 21:42
- MOTS-cconf 90%pending
MOTS-c: Mitochondrial Peptide Research Guide | Peptide Protocol Wiki Skip to main content 🧬 Peptide Protocol Wiki Peptides Side Effects New Learn Directory Tools Blog News About ⌘K ⌘K 🌱 New to Peptides?
- MOTS-cconf 90%pending
This positions MOTS-c as both a metabolic regulator and a stress-responsive signaling molecule.
- MOTS-cconf 90%pending
These findings were extended by subsequent studies showing that MOTS-c treatment increased physical performance in mouse models.
- MOTS-cconf 90%pending
This variant has been associated with exceptional longevity in Japanese and Northeast Asian populations, suggesting that MOTS-c function may influence human lifespan 3 .
- MOTS-cconf 90%pending
At the molecular level, MOTS-c activates the myogenic program and promotes satellite cell activation, suggesting direct effects on muscle regeneration and maintenance.
- MOTS-cconf 90%pending
Evidence Gaps and Limitations # Several significant gaps exist in the current understanding of MOTS-c that must be addressed before clinical translation can proceed.
- MOTS-cconf 90%pending
Because MOTS-c activates AMPK and promotes cell proliferation in certain contexts, potential oncogenic risks of chronic MOTS-c administration would need to be carefully evaluated before clinical development.
- MOTS-cconf 90%pending
PMID: 33473109): Demonstrated that MOTS-c levels increase with exercise, decline with age, and that MOTS-c treatment in aged mice improves physical performance and skeletal muscle homeostasis.
- MOTS-cconf 90%pending
Mitochondrial-derived peptide MOTS-c translocates to the nucleus in response to stress.
- MOTS-cconf 90%pending
How does MOTS-c affect aging?
- MOTS-cconf 90%pending
Report an Error Compare MOTS-c with Other Peptides MOTS-c vs Humanin Humanin and MOTS-c are complementary rather than competing peptides.
- Tesamorelinconf 90%pending
Peptide Protocol Wiki June 4, 2026 Retatrutide BPC-157 Tesamorelin + 6 more Guide 5 min read FDA Peptide Categories Explained: Category 1 vs Category 2 (2026) Understand the FDA peptide classification system.
- AOD-9604conf 90%pending
Peptide Protocol Wiki March 30, 2026 BPC-157 Thymosin Alpha-1 AOD-9604 + 16 more Guide 8 min read Weight Loss Peptides: Mechanisms, Evidence, and How They Compare A mechanism-focused guide to weight loss peptides — how GLP-1, GIP, and glucagon pathways drive fat loss, how single, dual, and triple agonists compare, and what the clinical evidence actually shows.
- BPC-157conf 90%pending
Peptide Protocol Wiki June 4, 2026 Retatrutide BPC-157 Tesamorelin + 6 more Guide 5 min read FDA Peptide Categories Explained: Category 1 vs Category 2 (2026) Understand the FDA peptide classification system.
- MOTS-cconf 90%pending
MOTS-c represents a unique endogenous signaling peptide with promising metabolic applications that remain in early preclinical stages → Related Articles Guide 9 min read Best Peptides to Stack with Retatrutide (2026 Research Guide) A 2026 research-focused review of the peptides most often discussed alongside retatrutide for GI side effects, lean-mass preservation, hair and skin changes, sleep, and adjunct fat loss — what the literature does and does not support.
- SS-31conf 90%pending
c vs SS-31 SS-31 is the more clinically advanced mitochondrial peptide with Phase 3 data and clear therapeutic applications in mitochondrial diseases;
- Tesamorelinconf 90%pending
Peptide Protocol Wiki February 28, 2026 Ipamorelin Retatrutide Tesamorelin + 12 more You Might Also Like Related content you may find interesting Peptide Mitochondrial SS-31 Peptide Anti-Aging Humanin Article guide Best Peptides to Stack with Retatrutide (2026 Research Guide) Article guide FDA Peptide Categories Explained: Category 1 vs Category 2 (2026) Table of Contents What is MOTS-c?
- Ipamorelinconf 90%pending
Peptide Protocol Wiki February 28, 2026 Ipamorelin Retatrutide Tesamorelin + 12 more You Might Also Like Related content you may find interesting Peptide Mitochondrial SS-31 Peptide Anti-Aging Humanin Article guide Best Peptides to Stack with Retatrutide (2026 Research Guide) Article guide FDA Peptide Categories Explained: Category 1 vs Category 2 (2026) Table of Contents What is MOTS-c?
- BPC-157conf 90%pending
From semaglutide to BPC-157.
- MOTS-cconf 90%pending
Peptide Protocol Wiki February 28, 2026 Ipamorelin Retatrutide Tesamorelin + 12 more You Might Also Like Related content you may find interesting Peptide Mitochondrial SS-31 Peptide Anti-Aging Humanin Article guide Best Peptides to Stack with Retatrutide (2026 Research Guide) Article guide FDA Peptide Categories Explained: Category 1 vs Category 2 (2026) Table of Contents What is MOTS-c?
- SS-31conf 90%pending
Peptide Protocol Wiki February 28, 2026 Ipamorelin Retatrutide Tesamorelin + 12 more You Might Also Like Related content you may find interesting Peptide Mitochondrial SS-31 Peptide Anti-Aging Humanin Article guide Best Peptides to Stack with Retatrutide (2026 Research Guide) Article guide FDA Peptide Categories Explained: Category 1 vs Category 2 (2026) Table of Contents What is MOTS-c?
- MOTS-cconf 90%pending
ol Quick-Reference Metabolic optimization, exercise mimetic effects, insulin sensitization, and anti-aging 💉 Dosing Amount 5-10 mg per injection Frequency 2-3 times per week or every 5 days Duration 4-6 weeks (20-day or 30-day protocols); repeat 2-4 times per year 💊 Administration Route SC Schedule 2-3 times per week or every 5 days Timing Morning or pre-exercise for metabolic activation ✓ Rotate injection sites 📅 Cycle Duration 4-6 weeks (20-day or 30-day protocols); repeat 2-4 times per year Repeatable Yes Course-based protocol with rest periods Preparation & Storage Diluent: Bacteriostatic water ⚗️ Suggested Bloodwork ( 6 tests) Fasting glucose and HbA1c When: Baseline Why: Baseline glycemic status (MOTS-c improves insulin sensitivity) Fasting insulin When: Baseline Why: Baseline insulin resistance marker CMP When: Baseline Why: Baseline metabolic panel Lipid panel When: Baseline Why: Baseline lipid profile CRP When: Baseline Why: Baseline inflammation Fasting glucose and fasting insulin When: 4 weeks Why: Assess metabolic improvement 💡 Key Considerations → Contraindication: No formal contraindications established; use cautiously given complete absence of human safety data Subscribe to unlock this content Get weekly peptide research summaries, new study alerts, and protocol updates — free.
- MOTS-cconf 90%pending
Restore access No thanks, continue reading Related Reading Peptide SS-31 mitochondrial-targeted antioxidant peptide Peptide Retatrutide triple-agonist metabolic peptide Peptide Cerebrolysin neuroprotective peptide mixture How MOTS-c works at the cellular level Overview of MOTS-c benefits and applications Scientific Details Molecular Formula C101H152N28O22S2 Molecular Weight 2174.6 Da CAS Number 1627580-64-6 Sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg What is MOTS-c? # MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino acid peptide encoded within the mitochondrial genome, specifically within the 12S ribosomal RNA gene (MT-RNR1).
- SS-31conf 90%pending
Restore access No thanks, continue reading Related Reading Peptide SS-31 mitochondrial-targeted antioxidant peptide Peptide Retatrutide triple-agonist metabolic peptide Peptide Cerebrolysin neuroprotective peptide mixture How MOTS-c works at the cellular level Overview of MOTS-c benefits and applications Scientific Details Molecular Formula C101H152N28O22S2 Molecular Weight 2174.6 Da CAS Number 1627580-64-6 Sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg What is MOTS-c? # MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino acid peptide encoded within the mitochondrial genome, specifically within the 12S ribosomal RNA gene (MT-RNR1).
- MOTS-cconf 90%pending
MOTS-c has attracted considerable research interest due to its role as a retrograde signaling molecule, communicating metabolic information from mitochondria back to the nucleus.
- MOTS-cconf 90%pending
This mechanism provides a molecular explanation for the broad metabolic effects observed following MOTS-c administration in preclinical models and distinguishes MOTS-c from direct pharmacological AMPK activators such as metformin or AICAR itself, which act through different upstream mechanisms.
- MOTS-cconf 82%pending
ol Quick-Reference Metabolic optimization, exercise mimetic effects, insulin sensitization, and anti-aging 💉 Dosing Amount 5-10 mg per injection Frequency 2-3 times per week or every 5 days Duration 4-6 weeks (20-day or 30-day protocols); repeat 2-4 times per year 💊 Administration Route SC Schedule 2-3 times per week or every 5 days Timing Morning or pre-exercise for metabolic activation ✓ Rotate injection sites 📅 Cycle Duration 4-6 weeks (20-day or 30-day protocols); repeat 2-4 times per year Repeatable Yes Course-based protocol with rest periods Preparation & Storage Diluent: Bacteriostatic water ⚗️ Suggested Bloodwork ( 6 tests) Fasting glucose and HbA1c When: Baseline Why: Baseline glycemic status (MOTS-c improves insulin sensitivity) Fasting insulin When: Baseline Why: Baseline insulin resistance marker CMP When: Baseline Why: Baseline metabolic panel Lipid panel When: Baseline Why: Baseline lipid profile CRP When: Baseline Why: Baseline inflammation Fasting glucose and fasting insulin When: 4 weeks Why: Assess metabolic improvement 💡 Key Considerations → Contraindication: No formal contraindications established; use cautiously given complete absence of human safety data Subscribe to unlock this content Get weekly peptide research summaries, new study alerts, and protocol updates — free.
dose: 10 mg · cycle: Cycle · timing: Morning · frequency: weekly · reconstitution: Bacteriostatic
- MOTS-cconf 58%pending
Identified MOTS-c as a 16-amino acid peptide encoded in the MT-RNR1 gene Demonstrated MOTS-c inhibits the folate cycle via MTHFD2, leading to AICAR accumulation and AMPK activation Intraperitoneal MOTS-c (5 mg/kg) prevented diet-induced obesity and insulin resistance in mice MOTS-c is an exercise-induced mitochondrial-enc
dose: 5 mg · cycle: cycle
- MOTS-cconf 50%pending
Clinical and Preclinical Evidence # Exercise Mimetic Data # The landmark 2015 study by Lee et al. in Cell Metabolism (PMID 25738459) demonstrated that intraperitoneal administration of MOTS-c (5 mg/kg) to mice fed a high-fat diet prevented obesity and insulin resistance, mimicking key metabolic benefits of exercise without actual physical activity 1 .
dose: 5 mg
- MOTS-cconf 60%pending
MOTS-c: Mitochondrial Peptide Research Guide | Peptide Protocol Wiki Skip to main content 🧬 Peptide Protocol Wiki Peptides Side Effects New Learn Directory Tools Blog News About ⌘K ⌘K 🌱 New to Peptides?
- MOTS-cconf 60%pending
Start the 7-step beginner guide Peptides Side Effects New Directory Learn Tools Blog News About MOTS-c 📋 Overview 🧬 Molecule 🔄 Similar ⚠️ Side Effects 💉 Dosing 🔬 Research 🚨 Risks 👥 Community 📊 Community Data Home Peptides MOTS-c Mitochondrial & Cellular Energy Weight Loss & Metabolism preclinical MOTS-c Also known as: Mitochondrial Open Reading Frame of the 12S rRNA Type-c Compare with 2 peptide s Research compiled by Peptide Protocol Wiki 📅 Updated January 29, 2026 Citations Verified TL;DR MOTS-c is a 16-amino acid mitochondrial-derived peptide that activates AMPK signaling and functions as an exercise mimetic.
- MOTS-cconf 60%pending
Browse all mitochondrial peptides → Table of Contents 📌 TL;DR • Mitochondrial-derived peptide with metabolic regulatory functions • Enhances insulin sensitivity and glucose metabolism • Exercise mimetic properties in preclinical models • AMPK pathway activation for cellular energy regulation Community-Reported Side Effects Anecdotal ? 📋 Protoc
- MOTS-cconf 60%pending
MOTS-c translocates from mitochondria to the nucleus under metabolic stress Nuclear MOTS-c binds chromatin and regulates ARE-containing genes Translocation occurs rapidly in response to glucose restriction and oxidative stress References # Related Reading # MOTS-c research studies and evidence MOTS-c dosing protocols MOTS-c side effects profile Humanin research guide Footnotes # Lee C, Zeng J, Drew BG, et al.
- conf 60%pending
Side Effects Database Report a Side Effect Learn Start Here What Are Peptides?
- MOTS-cconf 60%pending
Elucidating these contributions will be important for predicting therapeutic effects and potential side effects.
- MOTS-cconf 60%pending
MOTS-c represents a unique endogenous signaling peptide with promising metabolic applications that remain in early preclinical stages → Related Articles Guide 9 min read Best Peptides to Stack with Retatrutide (2026 Research Guide) A 2026 research-focused review of the peptides most often discussed alongside retatrutide for GI side effects, lean-mass preservation, hair and skin changes, sleep, and adjunct fat loss — what the literature does and does not support.
- MOTS-cconf 70%pending
ol Quick-Reference Metabolic optimization, exercise mimetic effects, insulin sensitization, and anti-aging 💉 Dosing Amount 5-10 mg per injection Frequency 2-3 times per week or every 5 days Duration 4-6 weeks (20-day or 30-day protocols); repeat 2-4 times per year 💊 Administration Route SC Schedule 2-3 times per week or every 5 days Timing Morning or pre-exercise for metabolic activation ✓ Rotate injection sites 📅 Cycle Duration 4-6 weeks (20-day or 30-day protocols); repeat 2-4 times per year Repeatable Yes Course-based protocol with rest periods Preparation & Storage Diluent: Bacteriostatic water ⚗️ Suggested Bloodwork ( 6 tests) Fasting glucose and HbA1c When: Baseline Why: Baseline glycemic status (MOTS-c improves insulin sensitivity) Fasting insulin When: Baseline Why: Baseline insulin resistance marker CMP When: Baseline Why: Baseline metabolic panel Lipid panel When: Baseline Why: Baseline lipid profile CRP When: Baseline Why: Baseline inflammation Fasting glucose and fasting insulin When: 4 weeks Why: Assess metabolic improvement 💡 Key Considerations → Contraindication: No formal contraindications established; use cautiously given complete absence of human safety data Subscribe to unlock this content Get weekly peptide research summaries, new study alerts, and protocol updates — free.
- Tesamorelin + SS-31conf 70%pending
Peptide Protocol Wiki February 28, 2026 Ipamorelin Retatrutide Tesamorelin + 12 more You Might Also Like Related content you may find interesting Peptide Mitochondrial SS-31 Peptide Anti-Aging Humanin Article guide Best Peptides to Stack with Retatrutide (2026 Research Guide) Article guide FDA Peptide Categories Explained: Category 1 vs Category 2 (2026) Table of Contents What is MOTS-c?
- Ipamorelin + MOTS-cconf 70%pending
Peptide Protocol Wiki February 28, 2026 Ipamorelin Retatrutide Tesamorelin + 12 more You Might Also Like Related content you may find interesting Peptide Mitochondrial SS-31 Peptide Anti-Aging Humanin Article guide Best Peptides to Stack with Retatrutide (2026 Research Guide) Article guide FDA Peptide Categories Explained: Category 1 vs Category 2 (2026) Table of Contents What is MOTS-c?
- Ipamorelin + SS-31conf 70%pending
Peptide Protocol Wiki February 28, 2026 Ipamorelin Retatrutide Tesamorelin + 12 more You Might Also Like Related content you may find interesting Peptide Mitochondrial SS-31 Peptide Anti-Aging Humanin Article guide Best Peptides to Stack with Retatrutide (2026 Research Guide) Article guide FDA Peptide Categories Explained: Category 1 vs Category 2 (2026) Table of Contents What is MOTS-c?
- Tesamorelin + MOTS-cconf 70%pending
Peptide Protocol Wiki February 28, 2026 Ipamorelin Retatrutide Tesamorelin + 12 more You Might Also Like Related content you may find interesting Peptide Mitochondrial SS-31 Peptide Anti-Aging Humanin Article guide Best Peptides to Stack with Retatrutide (2026 Research Guide) Article guide FDA Peptide Categories Explained: Category 1 vs Category 2 (2026) Table of Contents What is MOTS-c?
- MOTS-c + SS-31conf 70%pending
Peptide Protocol Wiki February 28, 2026 Ipamorelin Retatrutide Tesamorelin + 12 more You Might Also Like Related content you may find interesting Peptide Mitochondrial SS-31 Peptide Anti-Aging Humanin Article guide Best Peptides to Stack with Retatrutide (2026 Research Guide) Article guide FDA Peptide Categories Explained: Category 1 vs Category 2 (2026) Table of Contents What is MOTS-c?
- Tesamorelin + Ipamorelinconf 70%pending
Peptide Protocol Wiki February 28, 2026 Ipamorelin Retatrutide Tesamorelin + 12 more You Might Also Like Related content you may find interesting Peptide Mitochondrial SS-31 Peptide Anti-Aging Humanin Article guide Best Peptides to Stack with Retatrutide (2026 Research Guide) Article guide FDA Peptide Categories Explained: Category 1 vs Category 2 (2026) Table of Contents What is MOTS-c?
- AOD-9604 + BPC-157conf 50%pending
Peptide Protocol Wiki March 30, 2026 BPC-157 Thymosin Alpha-1 AOD-9604 + 16 more Guide 8 min read Weight Loss Peptides: Mechanisms, Evidence, and How They Compare A mechanism-focused guide to weight loss peptides — how GLP-1, GIP, and glucagon pathways drive fat loss, how single, dual, and triple agonists compare, and what the clinical evidence actually shows.
- Tesamorelin + BPC-157conf 50%pending
Peptide Protocol Wiki June 4, 2026 Retatrutide BPC-157 Tesamorelin + 6 more Guide 5 min read FDA Peptide Categories Explained: Category 1 vs Category 2 (2026) Understand the FDA peptide classification system.
- MOTS-c + SS-31conf 50%pending
Restore access No thanks, continue reading Related Reading Peptide SS-31 mitochondrial-targeted antioxidant peptide Peptide Retatrutide triple-agonist metabolic peptide Peptide Cerebrolysin neuroprotective peptide mixture How MOTS-c works at the cellular level Overview of MOTS-c benefits and applications Scientific Details Molecular Formula C101H152N28O22S2 Molecular Weight 2174.6 Da CAS Number 1627580-64-6 Sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg What is MOTS-c? # MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino acid peptide encoded within the mitochondrial genome, specifically within the 12S ribosomal RNA gene (MT-RNR1).